Literature DB >> 21491291

Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Edmund J Bini1, Steven Kritz, Lawrence S Brown, Jim Robinson, Don Alderson, John Rotrosen.   

Abstract

We sought to identify barriers to offering services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections in substance abuse treatment programs. We surveyed treatment program administrators and clinicians within the National Drug Abuse Treatment Clinical Trials Network to evaluate the availability of medical and non-medical services for patients with or at risk for acquiring these infections. A substantial proportion of programs do not offer services (particularly medical services) for these infections. The most commonly cited barriers were funding, health insurance benefits, patient acceptance, and staff training. The findings highlight a missed opportunity to positively impact these infectious disease epidemics. © Taylor & Francis Group, LLC

Entities:  

Mesh:

Year:  2011        PMID: 21491291      PMCID: PMC3102428          DOI: 10.1080/10550887.2011.554780

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  22 in total

1.  Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

Authors:  L H Bachmann; I Lewis; R Allen; J R Schwebke; L C Leviton; H A Siegal; E W Hook
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 2.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

3.  States and substance abuse treatment programs: funding and guidelines for infection-related services.

Authors:  Steven Kritz; Lawrence S Brown; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; Patricia Novo; John Rotrosen
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

4.  HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.

Authors:  R J Battjes; R W Pickens; L S Brown
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

5.  HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study.

Authors:  George E Woody; Robert Gallop; Lester Luborsky; Jack Blaine; Arlene Frank; Ihsan M Salloum; David Gastfriend; Paul Crits-Christoph
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

6.  Substance abuse and HIV infection.

Authors:  Henry Francis
Journal:  Top HIV Med       Date:  2003 Jan-Feb

7.  Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment.

Authors:  Cathy J Reback; Sherry Larkins; Steven Shoptaw
Journal:  AIDS Behav       Date:  2004-03

8.  Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).

Authors:  Robert L Hubbard; S Gail Craddock; Jill Anderson
Journal:  J Subst Abuse Treat       Date:  2003-10

9.  A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.

Authors:  Shiela M Strauss; Janetta M Astone; Don Des Jarlais; Holly Hagan
Journal:  Drug Alcohol Depend       Date:  2004-03-08       Impact factor: 4.492

10.  Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Authors:  Hillard Weinstock; Stuart Berman; Willard Cates
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb
View more
  20 in total

1.  Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Authors:  Andrew H Talal; Rositsa B Dimova; Randy Seewald; Raymond H Peterson; Marija Zeremski; David C Perlman; Don C Des Jarlais
Journal:  J Subst Abuse Treat       Date:  2012-03-08

2.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

3.  Missed Opportunities for HIV Testing Among STD Clinic Patients.

Authors:  Sharleen M Traynor; Lisa Rosen-Metsch; Daniel J Feaster
Journal:  J Community Health       Date:  2018-12

Review 4.  Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities.

Authors:  D Panagiotoglou; M Olding; B Enns; D J Feaster; C Del Rio; L R Metsch; R M Granich; S A Strathdee; B D L Marshall; M R Golden; S Shoptaw; B R Schackman; B Nosyk
Journal:  AIDS Behav       Date:  2018-09

5.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

6.  Health care reform, behavioral health, and the criminal justice population.

Authors:  Alison Evans Cuellar; Jehanzeb Cheema
Journal:  J Behav Health Serv Res       Date:  2014-10       Impact factor: 1.505

7.  HIV rapid testing in drug treatment: comparison across treatment modalities.

Authors:  Robert P Schwartz; Maxine L Stitzer; Daniel J Feaster; P Todd Korthuis; Anika A H Alvanzo; Theresa M Winhusen; Lillian Donnard; Ned Snead; Lisa R Metsch
Journal:  J Subst Abuse Treat       Date:  2012-09-27

Review 8.  Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.

Authors:  Philip Bruggmann; Alain H Litwin
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 9.  Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.

Authors:  Amber Arain; Geert Robaeys
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

10.  The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.

Authors:  Nora D Volkow; Julio Montaner
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.